Plameca (Plantas Medicinales y Complementos, S.A.) is a Spanish laboratory and manufacturer specializing in food supplements, medicinal plants, and natural wellness products. Founded in 1984 and headquartered in Barcelona, the company is recognized for applying pharmaceutical standards to the production of nutritional supplements. Core Operations and Expertise Product Portfolio: Plameca offers a diverse range of over 100 medicinal plants and 100+ food supplements. Its products focus on various therapeutic areas, including joint and bone health, cardiovascular support, digestive health, and liver care. Phytotherapy & Innovation: The company's foundation is built on a passion for phytotherapy (the study of medicinal plants). It maintains significant investment in Research and Development (R&D) to ensure its products are backed by clinical studies. Standards & Certifications: Operating in a GMP (Good Manufacturing Practice) environment, Plameca holds ISO 22000 and HACCP certifications. It is one of the leading suppliers of medicinal plants in Spain. Manufacturing Services: In addition to its own brand, Plameca provides private labeling and contract manufacturing services for global partners. Key Product Lines Curarti®: An osteoarticular line (Curarti Attack, Curarti Forte, Curarti Selectium) designed for joint health, containing high concentrations of turmeric. This line is promoted through high-profile sponsorships, including world padel champion Fernando Belasteguín. Aloe Verum®: A benchmark for European quality in aloe vera juice. These products use a specialized cold-process technology to maintain the plant's properties and include unpasteurized, organic (Bio), and premium versions with IASC certification. Specialized Supplements: 369k: Contains omega-3, EPA, and DHA for heart health. Alcachofera Capsudiet: Artichoke-based supplement for liver and digestive health. Plan 21 DiuDre 40+: Targeted at body weight control and fluid retention for individuals over 40. Corporate History and Ownership Founding: Established in 1984 by experts in medicinal plants. Ownership Transition: Previously part of the multinational pharmaceutical group SUANFARMA, Plameca underwent a significant change in April 2022. The company's management team acquired 100% of its equity to drive independent expansion, particularly in digital sales and pharmacy channels. Global Presence: Plameca currently exports its products to more than 30 countries. The company employs approximately 58 people.